InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ONCOLYTICS BIOTECH INC

ONCY Clue Score36
United States Fiscal year ends December CIK 0001129928
$0.56 +2.31% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.56 −71.44% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 31 May 2018. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Operating income−15.3Net income−15.1Fiscal year 2017Revenue6.2Operating income−15.6Net income−15.6Fiscal year 2018Revenue0.5 −91.1%Operating income−17.3Net income−17.0Fiscal year 2019Revenue0.0 −100.0%Operating income−20.4Net income−33.1EPS, diluted−1.50Fiscal year 2020Revenue0.0Operating income−25.5Net income−22.5EPS, diluted−0.56Fiscal year 2021Revenue0.0Operating income−26.2Net income−26.3EPS, diluted−0.49Fiscal year 2022Operating income−26.9Net income−24.8EPS, diluted−0.43Fiscal year 2023Operating income−33.8Net income−27.8EPS, diluted−0.41Fiscal year 2024Operating income−25.5Net income−22.8EPS, diluted−0.30Fiscal year 2025Operating income−28.7Net income−28.8EPS, diluted−0.30
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a 6.2 0.5 0.0 0.0 0.0 n/a n/a n/a n/a
Growth −91.1% −100.0%
Operating income −15.3 −15.6 −17.3 −20.4 −25.5 −26.2 −26.9 −33.8 −25.5 −28.7
Net income −15.1 −15.6 −17.0 −33.1 −22.5 −26.3 −24.8 −27.8 −22.8 −28.8
Growth
EPS, diluted n/a n/a n/a −1.50 −0.56 −0.49 −0.43 −0.41 −0.30 −0.30

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Fiscal year 2017Operating margin−252.4%Net margin−252.6%Fiscal year 2018Operating margin−3,153.7%Net margin−3,110.6%Fiscal year 2019Fiscal year 2020Fiscal year 2021Fiscal year 2022Fiscal year 2023Fiscal year 2024Fiscal year 2025
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a −252.4% −3,153.7% n/a n/a n/a n/a n/a n/a n/a
Net margin n/a −252.6% −3,110.6% n/a n/a n/a n/a n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Capital expenditure−0.0Fiscal year 2017Capital expenditure−0.1Fiscal year 2018Capital expenditure−0.1Fiscal year 2019Capital expenditure−0.0Fiscal year 2020Capital expenditure−0.0Fiscal year 2021Capital expenditure−0.3Fiscal year 2022Capital expenditure−0.1Fiscal year 2023Capital expenditure−0.0Fiscal year 2024Operating cash flow−19.9Capital expenditure−0.2Free cash flow−20.1Fiscal year 2025Operating cash flow−20.1Capital expenditure−0.0Free cash flow−20.1
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow n/a n/a n/a n/a n/a n/a n/a n/a −19.9 −20.1
Capital expenditure −0.0 −0.1 −0.1 −0.0 −0.0 −0.3 −0.1 −0.0 −0.2 −0.0
Free cash flow n/a n/a n/a n/a n/a n/a n/a n/a −20.1 −20.1
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash12.0Shareholders’ equity10.7Fiscal year 2017Cash11.8Shareholders’ equity8.3Fiscal year 2018Cash13.7Shareholders’ equity6.2Fiscal year 2019Cash14.1Shareholders’ equity−0.1Fiscal year 2020Cash31.2Shareholders’ equity24.8Fiscal year 2021Cash41.3Shareholders’ equity36.1Fiscal year 2022Cash11.7Shareholders’ equity26.5Fiscal year 2023Cash26.4Shareholders’ equity19.6Fiscal year 2024Cash11.1Shareholders’ equity3.3Fiscal year 2025Cash5.2Shareholders’ equity−3.8
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 12.0 11.8 13.7 14.1 31.2 41.3 11.7 26.4 11.1 5.2
Shareholders’ equity 10.7 8.3 6.2 −0.1 24.8 36.1 26.5 19.6 3.3 −3.8

In millions of CAD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of CAD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020† 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
n/a 6.2 0.5 0.0 0.0 0.0 n/a n/a n/a n/a
Growth −91.1% −100.0%
9.8 9.4 10.0 10.8 12.9 12.9 15.4 17.7 21.6 n/a
n/a n/a n/a n/a 12.5 13.3 11.5 16.1 13.3 n/a
−15.3 −15.6 −17.3 −20.4 −25.5 −26.2 −26.9 −33.8 −25.5 −28.7
Growth
−15.1 −15.5 −16.5 −33.1 −22.5 −26.3 −24.8 −27.7 −22.7 −28.7
0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.1 0.1 0.1
−15.1 −15.6 −17.0 −33.1 −22.5 −26.3 −24.8 −27.8 −22.8 −28.8
Growth
Per share
n/a n/a n/a −1.50 −0.56 −0.49 −0.43 −0.41 −0.30 −0.30
n/a n/a n/a −1.50 −0.56 −0.49 −0.43 −0.41 −0.30 −0.30
Growth
12.6 13.9 16.0 22.1 40.3 53.5 58.0 67.6 76.5 95.9
12.6 13.9 16.0 22.1 40.3 53.5 58.0 67.6 76.5 95.9
Growth +10.4% +14.9% +38.2% +82.2% +32.7% +8.4% +16.5% +13.1% +25.3%

† The diluted share count jumps at 2020, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Shown in CAD as filed; the screener converts to dollars.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 10 of 10 years on file.